MICROBIAL INSPIRED THERAPEUTICS

Axial Therapeutics, Inc.

Application Filed: 2018-07-10
Trademark Application Details
Trademark Logo MICROBIAL INSPIRED THERAPEUTICS

Mark For: MICROBIAL INSPIRED THERAPEUTICS™ trademark registration is intended to cover the categories of chemical or biochemical products, namely, small molecules, probiotic bacteria, probiotic bacterial cultures, and/or microbes for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut; microbes, chemicals and/or biochemicals for use in the manufacture of pharmaceutical preparations, probiotic supplements, and/or nutritional supplements; probiotic bacteria, probiotic bacterial cultures, and/or biochemicals for in vitro scientific or research use. [all]

Status

2021-07-16 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88031390
Mark Literal ElementsMICROBIAL INSPIRED THERAPEUTICS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-03-17
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 001: Raw or Partly Prepared Materials
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 010: Fertilizers
  • 026: Measuring and Scientific Appliances
  • 046: Foods and Ingredients of Foods
Primary International Class
  • 001 - Primary Class
  • (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameIan W. Gillies
Attorney Docket NumberAXLB.010T
Law Office AssignedL40
Employee NameDUONG, ANGELA GAW

Timeline

2018-07-10Application Filed
2019-12-19Location: PUBLICATION AND ISSUE SECTION
2019-12-19Status: Live/Pending
2020-01-01Transaction Date
2020-01-21Published
2020-01-21Published for Opposition
2020-03-17Location: INTENT TO USE SECTION
2021-02-08Status: A second request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: AXIAL THERAPEUTICS, INC.
Address400 TRADE CENTER DR. SUITE 6990 WOBURN, MASSACHUSETTS UNITED STATES 01801
Legal Entity TypeCorporation
Legal Entity StateDELAWARE
Party: Axial Biotherapeutics, Inc.
AddressSuite 1555 800 Boylston Street Boston DE 02199
Legal Entity Type
Legal Entity StateDE

*multiple parties listed, check assignment documents for ownership information

Documents

Attorney of Record

Ian W. Gillies
KNOBBE, MARTENS, OLSON & BEAR, LLP
14TH FLOOR
2040 MAIN STREET
IRVINE CA 92614

Good, Services, and Codes


IC 001. US 001 005 006 010 026 046. G & S: Chemical or biochemical products, namely, small molecules, probiotic bacteria, probiotic bacterial cultures, and/or microbes for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut; microbes, chemicals and/or biochemicals for use in the manufacture of pharmaceutical preparations, probiotic supplements, and/or nutritional supplements; probiotic bacteria, probiotic bacterial cultures, and/or biochemicals for in vitro scientific or research use
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut
IC 042. US 100 101. G & S: Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
IC 044. US 100 101. G & S: Providing medical information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
D10000"MICROBIAL" AND "THERAPEUTICS"
GS0051Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut

Trademark Filing History

DescriptionDateProceeding Number
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2021-03-24
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-02-10
TEAS EXTENSION RECEIVED2021-02-08
EXTENSION 2 GRANTED2021-02-0898765
EXTENSION 2 FILED2021-02-0898765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-09-18
TEAS EXTENSION RECEIVED2020-09-16
EXTENSION 1 GRANTED2020-09-1698765
EXTENSION 1 FILED2020-09-1698765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-03-17
PUBLISHED FOR OPPOSITION2020-01-21
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-01-21
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-01-01
ASSIGNED TO LIE2019-12-1970633
APPROVED FOR PUB - PRINCIPAL REGISTER2019-12-17
TEAS/EMAIL CORRESPONDENCE ENTERED2019-11-2388889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-11-22
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-11-2288889
PRIORITY ACTION WRITTEN2019-05-2983695
PRIORITY ACTION E-MAILED2019-05-296326
NOTIFICATION OF PRIORITY ACTION E-MAILED2019-05-296326
TEAS/EMAIL CORRESPONDENCE ENTERED2019-04-3088889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-04-29
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-04-2988889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-10-306325
NON-FINAL ACTION WRITTEN2018-10-3083695
NON-FINAL ACTION E-MAILED2018-10-306325
ASSIGNED TO EXAMINER2018-10-2983695
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-07-14
NEW APPLICATION ENTERED IN TRAM2018-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed